CA-4948 is primarily investigated for its potential in cancer therapy, particularly in targeting specific pathways involved in tumor growth and survival. It is studied for its ability to inhibit certain proteins or enzymes that are crucial for the proliferation of cancer cells. Researchers are exploring its efficacy in treating hematologic malignancies, such as certain types of leukemia and lymphoma, where it may help induce apoptosis or halt the progression of the disease. Additionally, CA-4948 is being evaluated in combination with other therapeutic agents to enhance its anti-cancer effects and overcome resistance mechanisms. Its application extends to preclinical and clinical trials, aiming to establish its safety, dosage, and effectiveness in human patients.